Results 111 to 120 of about 33,608 (178)

Basal T cell activation predicts yellow fever vaccine response independently of cytomegalovirus infection and sex-related immune variations. [PDF]

Cell Rep Med
Santos-Peral A, Zaucha M, Nikolova E, Yaman E, Puzek B, Winheim E, Goresch S, Scheck MK, Lehmann L, Dahlstroem F, Karimzadeh H, Thorn-Seshold J, Jia S, Luppa F, Pritsch M, Butt J, Metz-Zumaran C, Barba-Spaeth G, Endres S, Kim-Hellmuth S, Waterboer T, Krug AB, Rothenfusser S.   +22 more
europepmc   +1 more source

Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals. [PDF]

An Bras Dermatol, 2021
Almeida LR, Criado RF, Criado PR, Ensina LF, Abdalla BMZ, Quaresma JAS.   +5 more
europepmc   +1 more source

Reaching Forest Workers with Yellow Fever Vaccine Through Engagement of the Private Sector in Central African Republic. [PDF]

Vaccines (Basel)
Noufack G, Bissengue P, Zobanga JK, Malingao JSC, Keita M, Razaiarimanga MC, Raguenaud ME.   +6 more
europepmc   +1 more source

Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivity. [PDF]

PLoS Negl Trop Dis
Saucha CVV, Maia MLS, Sousa ESS, de Oliveira PMN, Xavier JR, de Castro TDM, Cruz RLS, Schwarcz WD, Pereira RC, Azevedo AS, de Filippis AMB, Ferroco CLV, Pizzini GLC, Brum RCS, Secundino L, Andrade MFS, de Oliveira RVC, Simões M, Cerbino-Neto J, Martins-Filho OA, Campi-Azevedo AC, de Lima SMB, Camacho LAB, Collaborative Group for Yellow Fever Vaccine Studies.   +23 more
europepmc   +1 more source

A clinician's perspective on yellow fever vaccine-associated neurotropic disease. [PDF]

J Travel Med, 2020
Lecomte E, Laureys G, Verbeke F, Domingo Carrasco C, Van Esbroeck M, Huits R.   +5 more
europepmc   +1 more source

Electron transport chain capacity expands yellow fever vaccine immunogenicity. [PDF]

EMBO Mol Med
Mok DZ, Tng DJ, Yee JX, Chew VS, Tham CY, Ooi JS, Tan HC, Zhang SL, Lin LZ, Ng WC, Jeeva LL, Murugayee R, Goh KK, Lim TP, Cui L, Cheung YB, Ong EZ, Chan KR, Ooi EE, Low JG.   +19 more
europepmc   +1 more source

Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial. [PDF]

Vaccine
Osei I, Schmidt-Chanasit J, Licciardi PV, Secka O, D'Alessandro U, Salaudeen R, Sarwar G, Clarke E, Mohammed NI, Nguyen C, Greenwood B, Jansen S, Mackenzie GA.   +12 more
europepmc   +1 more source

Immune response induced by standard and fractional doses of 17DD yellow fever vaccine. [PDF]

NPJ Vaccines
Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, Fernandes EG, Sato HK, Fantinato FFST, Domingues CMAS, Kallás EG, Tomiyama HTI, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, Schwarcz WD, de Souza Azevedo A, Trindade GF, Ano Bom APD, da Silva AMV, Fernandes CB, Camacho LAB, de Sousa Maia ML, Collaborative Group for Studies of Yellow Fever Vaccine, Martins-Filho OA, do Antonelli LRDV.   +29 more
europepmc   +1 more source

Impact of HIV-Related Immune Impairment of Yellow Fever Vaccine Immunogenicity in People Living with HIV-ANRS 12403. [PDF]

Vaccines (Basel)
Caetano DG, Toledo TS, de Lima ACS, Giacoia-Gripp CBW, de Almeida DV, de Lima SMB, Azevedo AS, Morata M, Grinsztejn B, Cardoso SW, da Costa MD, Brandão LGP, Bispo de Filippis AM, Scott-Algara D, Coelho LE, Côrtes FH.   +15 more
europepmc   +1 more source

Fatal viscerotropic and neurotropic disease after yellow fever vaccine: a rare manifestation leading to diagnosis of severe combined immunodeficiency in an infant. [PDF]

Rev Inst Med Trop Sao Paulo
Vieira LJT, Goebel GA, Barcelos Y, Cunha LO, Santos LTM, Romanelli RMC, Minafra FG, Carvalho AL, Carvalho LFA, Diniz LMO.   +9 more
europepmc   +1 more source